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Measles virus (MV) is the causative agent of subacute sclerosing panencephalitis (SSPE). We previously
reported that the F gene of the SSPE Osaka-2 strain is the major determinant of MV neurovirulence.
Because the sites and extents of mutations differ among SSPE strains, it is necessary to determine the
mutations responsible for the SSPE-speciﬁc phenotypes of individual viral strain. In this study, recom-
binant viruses containing the envelope-associated genes from the SSPE Osaka-1 strain were generated in
the IC323 wild-type MV background. Hamsters inoculated with MV containing the H gene of the Osaka-1
strain displayed hyperactivity and seizures, but usually recovered and survived. Hamsters inoculated
with MV containing the F gene of the Osaka-1 strain displayed severe neurologic signs and died. Amino
acid substitutions in the heptad repeat A and C regions of the F protein, including a methionine-to-valine
substitution at amino acid 94, play major roles in neurovirulence.
& 2015 Elsevier Inc. All rights reserved.Introduction
Measles virus (MV) is a member of the genus Morbillivirus
within the family Paramyxoviridae. The MV genome is 15,894
bases, forming a nonsegmented, single-stranded, negative-sense
RNA molecule encoding six genes: N (nucleocapsid), P (phospho),
M (matrix), F (fusion), H (hemagglutinin), and L (large). It also
contains leader and trailer sequences at its 30 and 50 termini,
respectively (Grifﬁn, 2013).
Subacute sclerosing panencephalitis (SSPE) is a fatal neurologic
complication of persistent MV infection in the brain (Schneider-
Schaulies et al., 2003). SSPE occurs in about 16 cases per one
million cases of measles in Japan (Okuno et al., 1989), although a
US study reported that SSPE develops in about 220 cases per one
million cases of measles (Bellini et al., 2005). MV isolates from the
brains of patients with SSPE differ from those from the nasal or
blood specimens of patients with acute measles, and SSPE strainsGraduate School of Medicine,
u, Osaka 545-8585, Japan.
Ayata).are known to contain many mutations in their genomes (Ayata
et al., 1989; Cattaneo et al., 1988a, 1988b; Schmid et al., 1992).
Therefore, it is important to investigate the inﬂuence of these
mutations and to understand the molecular mechanisms of MV
persistence and the pathogenesis of SSPE. SSPE strains cause
neurologic disease in rodents, including hamsters and mice, fol-
lowing their intracerebral inoculation (Albrecht et al., 1977;
Johnson and Byington, 1971, 1977; Katz et al., 1970; Sugita, et al.,
1984; Thormar et al., 1977).
We have previously demonstrated that recombinant MVs
containing the F and/or H genes of the SSPE Osaka-2 MV strain
induce acute encephalitis in hamsters (Ayata et al., 2010). Muta-
tions within the F and H genes were found to be responsible for
the neurovirulence of the SSPE Osaka-2 strain. Further studies
indicated that the T461I or Y442D mutation in the F1 extracellular
domain of the Osaka-2 strain F protein plays a major role in its
neurovirulence in hamsters. A single amino acid substitution,
T461I, in the F protein resulted in fatal outcomes in hamsters. The
substitutions in the F protein responsible for MV neurovirulence
also correlated with its ability to induce syncytial formation in
Vero cells.
Table 1
The SSPE Osaka-1 strain and recombinant viruses containing the M, F, or H genes,
or both F and H genes of the Osaka-1 strain were used as inoculates to determine
their neurovirulence in hamsters.
Virus Titer (PFU)a Incidence of
diseaseb
Onset of disease
(days)c
B95a Vero
IC323 11,500 o0.5 0/4 – (–), – (–), – (–), – (–)
OSA1/FrV 165 175 4/4 3 (0), 3 (1), 3 (1), 3 (2*)
OSA1/FrV 83 88 9/9 3 (0), 3 (1*), 3 (2*), 4
(1*), 4 (2)
4 (2*), 4 (3), 6 (3*), 7
(2*)
IC/[P-M5U]
OSA1-M
4100 o0.5 0/5 – (–), – (–), – (–), – (–),
– (–)
IC/[P-M6U]
OSA1-M
2600 o0.5 0/5 – (–), – (–), – (–), – (–),
– (–)
IC/OSA1-F 5650 10 6/6 3 (1*), 3 (1*), 3 (2), 3
(2), 3 (2), 4
IC/OSA1-H 5000 o0.75 6/6 6 (6), 6 (270), 6 (–), 7
(–), 7 (–), 10 (–)
IC/OSA1-FH 1000 200 6/6 2 (1), 2 (1), 2 (1), 2 (1*),
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strains (Cattaneo et al., 1988b; Schmid et al., 1992), and sibling
virus variants with different sequences can replicate in the brain of
a single patient (Ayata et al., 1998; Baczko et al., 1993; Seto et al.,
1999). Viral stocks cultured in different cell types, prepared from
different passage numbers of SSPE MV strains, or maintained in
different laboratories also differed in their neurovirulence when
they were transferred into rodent brains. For example, the SSPE
Biken strain isolated in human embryonic lung cells was originally
neurovirulent in hamsters, but lost its virulence after serial pas-
sages, and somehow regained it after passage in neural cells in a
different laboratory (Sakaguchi et al., 1985). Therefore, it is
necessary to determine the mutations responsible for the SSPE-
speciﬁc phenotypes of individual viral strain. For this purpose, a
genetically homogeneous viral stock is required, which could be
developed with a reverse genetic system. In this study, we used a
strategy similar to the one we used previously, but with an SSPE
Osaka-1 strain derived from a different patient. This strain con-
tains mutations in the envelope-associated genes, at sites and in
numbers that differed from those in the Osaka-2 strain.2 (1*), 2 (1*)
a The titer of the inoculum (50 mL/brain) was determined on B95a or Vero cells.
b Number of hamsters showing neurologic signs/number of inoculated ham-
sters.
c Figures refer to individual hamsters. The number of days from intracerebral
inoculation to onset of neurologic signs is indicated. ‘–’, no signs. The number of
days from onset to death or to euthanization (with an asterisk) is indicated in
parentheses. ‘–’, the hamster did not die.Results
Recombinant MVs containing the F and/or H gene of the Osaka-1
strain are neurovirulent in hamsters
We ﬁrst evaluated the neurovirulence of the SSPE Osaka-1
strain in hamsters. The isolation of the SSPE Osaka-1 strain has
been described previously (Ogura et al., 1997). Brieﬂy, a girl had
measles at 1 year old, developed SSPE at 17 years, and died at 25
years. A sibling virus, OSA1/FrV, was isolated from the patient by
coculturing Vero cells with a brain specimen from the frontal lobe
of the patient, which was obtained at autopsy. Infectious cell-free
virus was prepared by treating the culture with cytochalasin D, as
described previously (Ishida et al., 2004), because the virus was
strictly nonproductive. Hamsters (3 weeks old) were inoculated
intracerebrally with 165 or 83 PFU of SSPE Osaka-1. The hamsters
suffered generalized seizures after 3–7 days postinfection and died
within 3 days after seizure onset (Table 1).
To identify the genes and mutations responsible for the neuro-
virulence of the Osaka-1 strain, we generated recombinant MVs based
on an IC323 wild-type MV that contained the M, F, or H gene from the
Osaka-1 strain. We ﬁrst generated and evaluated a recombinant MV
that contained the Osaka-1 M gene. There was a single nucleotide
difference in the P gene between two sibling virus isolates, which
affected the transcription of the M gene (Ayata et al., 2002). We
constructed two recombinant MVs, IC/[P-M5U]OSA1-M and IC/[P-
M6U]OSA1-M, which contained a stretch of ﬁve or six uracils (Us) at
the end of the P gene, respectively (Supplementary Fig. 1). The IC/[P-
M5U]OSA1-M and IC/[P-M6U]OSA1-M viruses were defective in the
production of infectious cell-free virus, similar to SSPE strains such as
the Osaka-1 strain (Supplementary Fig. 2). Hamsters were inoculated
intracerebrally with these recombinant viruses to ascertain their
neurovirulence. For this experiment, we prepared a cell-free viral
stock by treating the cells with cytochalasin D, and inoculated the
maximum amount of viral stock possible. Hamsters inoculated with
virus containing the M gene of the Osaka-1 strain showed no neu-
rologic signs during the 10-week observation period (Table 1).
Recombinant MVs containing either the F (IC/OSA1-F) or H
gene (IC/OSA1-H) of the Osaka-1 strain, or both the F and H genes
(IC/OSA1-FH) were then prepared (Supplementary Fig. 1). The viral
titers of the recombinant MVs containing the F and/or H genes
were compared (Supplementary Fig. 2). The infectious cell-free
viral titers of the IC/OSA1-F and IC/OSA1-H recombinant MVs were
compared with that of IC323 after 3 days, and had decreased to11.579.8% and 7.075.6%, respectively. No cell-free virus was
detected in the culture infected with IC/OSA1-FH, containing both
F and H genes of the Osaka-1 strain. We then prepared an infec-
tious cell-free viral stock by treating cells with cytochalasin D.
Hamsters were inoculated with the chimeric virus containing the F
gene of the Osaka-1 strain (IC/OSA1-F) at a dose of 5650 PFU.
These hamsters displayed generalized seizures at 3–4 days post-
infection, and all but one hamster died 2 days after the onset of
seizures (Table 1). Hamsters were also inoculated with virus con-
taining the H gene of the Osaka-1 strain (IC/OSA1-H) at a dose of
5000 PFU. These displayed hypersensitivity and generalized sei-
zures, but their onset was delayed compared with those of the IC/
OSA1-F-treated hamsters. Neurologic signs were apparent at 6–10
days postinfection. All but one of the hamsters recovered after 1–2
days and survived for more than 6 months (Table 1). Hamsters
were also inoculated with IC/OSA1-FH at a dose of 1000 PFU. The
viral titer of IC/OSA1-FH was much lower than those of the other
recombinant viruses because it was difﬁcult to make a high-titer
viral stock from cells infected with the virus containing both F and
H genes of the Osaka-1 strain. Nonetheless, the IC/OSA1-FH virus
was extremely neurovirulent, and all the hamsters experienced
generalized seizures at 2 days postinfection and died 1 day after
seizure onset (Table 1).
Because the hamsters inoculated with the virus containing the
F protein of the Osaka-1 strain developed more severe disease
than those inoculated with the virus containing the H protein of
the Osaka-1 strain, we evaluated the individual amino acid sub-
stitutions in the F protein to determine their contribution to the
enhanced fusogenic activity of the virus in vitro and the acquisition
of neurovirulence in hamsters.
Amino acid substitutions in the F2 region of the F protein are
responsible for enhanced fusion of Vero cells and neurovirulence in
hamsters
MVs derived from SSPE can induce syncytia in Vero cells
through a currently unknown receptor. The coexpression of the F
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Fig. 1. MV F protein and schematic diagrams of constructs. HRA, HRB, and HRC are shown. The signal peptide (SP), fusion peptide (FP), and a transmembrane domain (TM)
are also indicated. Vertical lines indicate amino acids that differ from those in the IC323 strain. For the F and H coexpression experiments, gene fragments were inserted into
a eukaryotic expression vector, pME18S. For the recombinant MV constructs, plasmids were prepared by replacing the whole F gene fragment from a plasmid containing the
IC323 viral genome. Neurologic signs observed in the hamsters inoculated with individual recombinant virus are indicated: –, no signs; þ , hypersensitivity and generalized
seizures.
Fig. 2. Syncytia formation induced by the F protein with various mutations. Vero cells were cotransfected with plasmid DNA encoding the MV H and F proteins. The mutated
F genes were: (A) F:IC323; (B) F:OSA1; (C) F:OSA1ext; (D) F:OSA1cyt; (E) F:OSA1-F1ext; (F) F:OSA1-F2; (G) F:M94V&A167T; and (H) F:M94V&N191S. At 24 h posttransfection,
the cells were ﬁxed and stained with a monoclonal antibody directed against the H protein, and then with a ﬂuorescein-isothiocyanate-conjugated anti-mouse antibody.
Scale bar, 100 mm.
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induced syncytia (the schematic diagrams for the F protein mutant
constructs are shown in Fig. 1 and the syncytia formation induced
by their coexpression is shown in Fig. 2). The region responsible
for this enhanced fusogenic activity in Vero cells was located in an
extracellular domain containing mutations, designated the F2
region (Fig. 2F). There were three amino acid substitutions (I62T,
T82I, and M94V, excluding the V5M substitution in the signal
peptide) in the F2 region (Fig. 1, F:OSA1F2). However, an F protein
containing either the I62T or T82I substitution did not induce
syncytia, whereas an F protein containing the M94V substitution
induced some microscopically detectable syncytia. We then tested
F proteins with different combinations of substitutions in the F2
region. The F proteins containing double substitutions (Fig. 1, F:
I62T&T82I, F:I62T&M94V, and F:T82I&M94V) induced micro-
scopically detectable syncytia. Among the three substitutions, the
M94V substitution appeared to be relatively important, but its
fusogenic activity was far less efﬁcient than that of F:OSA1-F2,
which contained all three substitutions.
Recombinant MVs containing substitutions in the F2 domain of the
F proteinwere constructed to determine the relationship between the
fusogenic activity of the virus and its neurovirulence in hamsters.
Hamsters inoculated with virus containing the I62T, T82I, or M94V
substitution in the F protein showed no neurologic signs when
inoculated at a dose of 2000 PFU (Fig. 1, F:I62T, F:T82I, and F:M94V;
Supplementary Table 1, IC/F:I62T, IC/F:T82I, and IC/F:M94V). Ham-
sters inoculated with virus containing the M94V substitution at a
higher dose (20,000 PFU) remained healthy. Hamsters inoculated
with virus containing both I62T and T82I substitutions showed a
transient weight loss but not apparent neurologic signs (Fig. 1, F:
I62T&T82I; Supplementary Table 1, IC/F:I62T&T82I). Neurovirulence
was apparent in hamsters inoculated with virus containing an F
protein with the I62T and M94V substitutions or the T82I and M94V
substitutions (Fig. 1, F:I62T&M94V or F:T82I&M94V; Supplementary
Table 1, IC/F:I62T&M94V or IC/F:T82I&M94V). However, infection
with none of the recombinant viruses was fatal in the hamsters.
Some combinations of amino acid substitutions in the F1 extracellular
region or between the F1 and F2 regions of the F protein are also
responsible for the enhanced fusion of Vero cells and neurovirulence
in hamsters
Although changes in the extracellular F1 region caused no
fusion enhancement effects (Fig. 1, F:OSA1F1ext; Fig. 2E), we
evaluated the individual amino acid substitutions in this region for
their effects on fusion activity. The F protein containing either an
N191S or H419Q substitution (Fig. 1, F:N191S or F:H419Q) did not
cause syncytia, whereas the F protein containing the A167T sub-
stitution (Fig. 1, F:A167T) induced some microscopically detectable
syncytia in the cells. F proteins containing both A167T and N191S
or A167T and H419Q substitutions (Fig. 1, F:A167T&N191S or F:
A167T&H419Q) also induced microscopically detectable syncytia.
Recombinant MVs containing substitutions in the extracellular
F1 domain of the F protein were constructed and tested for their
neurovirulence in hamsters. Hamsters inoculated with virus con-
taining the N191S or H419Q substitution in the F protein showed
no neurologic signs when inoculated at a dose of 2000 PFU (Fig. 1,
F:N191S or F:H419Q; Supplementary Table 1, IC/F:N191S or IC/F:
H419Q). Hamsters inoculated with virus containing the A167T and
N191S or the N191S and H419Q substitutions in the F protein also
showed no neurologic signs (Fig. 1, F:A167T&N191S or F:
N191S&H419Q; Supplementary Table 1, IC/F:A167T&N191S or IC/F:
N191S&H419Q). In contrast, hamsters inoculated with virus con-
taining the A167T substitution showed mild neurologic signs(Fig. 1, F:A167T; Supplementary Table 1, IC/F:A167T). One of ﬁve
hamsters inoculated with 2000 PFU of this virus showed hyper-
activity in response to audio stimuli at 7 days postinfection.
Transient weight loss and growth retardation were noted in all ﬁve
hamsters. Two of the ﬁve hamsters inoculated with 20,000 PFU of
this virus showed hyperactivity in response to audio stimuli at
5 days postinfection. Hamsters inoculated with virus containing
the A167T and H419Q substitution also showed mild neurologic
signs (Fig. 1, F:A167T&H419Q; Supplementary Table 1, IC/F:
A167T&H419Q). All the hamsters inoculated with 2000 PFU of this
virus showed hyperactivity in response to audio stimuli at 5 or
6 days postinfection. All the hamsters inoculated with these
viruses recovered quickly, and survived the remainder of the 5-
week observation period with no neurologic signs (Supplementary
Table 1, IC/F:A167T and IC/F:A167T&H419Q). Therefore, viruses
containing A167T only or the A167T and H419Q substitutions
induced mild encephalitis, although we observed no neuroviru-
lence in the hamsters inoculated with a recombinant MV con-
taining all three substitutions in the F1 extracellular domain.
F proteins with double mutations in the F2 and F1 regions
(Fig. 1, F:M94V&A167T or F:M94V&N191S) were also tested for
their fusogenic activity and neurovirulence in hamsters. Both
constructs induced clearly apparent syncytia, similar to those
induced by F:OSA1-F2 (Fig. 2G and H). Each amino acid substitu-
tion may have affected the conformation and function of the F
protein to different extents. Viruses containing substitutions in the
F1 and F2 regions were also neurovirulent in hamsters, which
showed neurologic signs such as hyperactivity and seizure (Fig. 1,
F:M94V&A167T and F:M94V&N191S; Supplementary Table 1, IC/F:
M94V&A167T and IC/F:M94V&N191S). Hamsters inoculated with
IC/F:M94V&N191S recovered, but those inoculated with IC/F:
M94V&A167T died.
Viral rescue and histopathological examination of hamster brains
inoculated with recombinant viruses
Viruses were rescued by the coculture of B95a cells with brain
cells from hamsters that had been killed in the terminal stage of
infection. However, no virus was rescued from hamsters that
showed no neurologic signs or were killed in the stage of clinical
recovery.
A histopathological examination of the brains from the killed
hamsters inoculated with IC/OSA1-F or IC/OSA1-FH revealed an
indistinct layer of pyramidal cells in the CA1–CA3 ﬁelds of their
hippocampi (Fig. 3B and D). Higher magniﬁcation of the lesions
showed neuronal necrosis in the CA1–CA3 ﬁelds (Supplementary
Fig. 3B and D). Relatively mild lesions were observed in the CA1
ﬁelds of the hippocampi of hamsters inoculated with the IC/OSA1-
H virus (Fig. 3C, Supplementary Fig. 3C). In contrast, no lesions
were detected in the hamsters inoculated with the IC323 virus
(Fig. 3A, Supplementary Fig. 3A).
Hamsters inoculated with recombinant viruses containing
mutant F genes were also subjected to histopathological exam-
ination (Fig. 3). The typical layer of pyramidal cells spanning the
CA1–CA3 ﬁelds of the hippocampi had disappeared in the ham-
sters inoculated with the virus containing the extracellular domain
(IC/F:OSA1ext), the F2 domain (IC/F:OSA1-F2) of the Osaka-1 F
protein, or IC/F:I62T&M94V (Fig. 3E, G, and H). In contrast, the
same region of the brain in hamsters inoculated with the virus
containing the F1 extracellular domain of the Osaka-1 F protein
(IC/F:OSA1-F1ext) (Fig. 3F) appeared similar to that in hamsters
inoculated with IC323 (Fig. 3A). Higher-magniﬁcation photographs
revealed severe lesions with necrotic pyramidal cells around the
CA1–CA3 ﬁelds of the hippocampi in hamsters inoculated with
CA1CA2
CA3
DG
Fig. 3. Histopathological ﬁndings in the hamster hippocampus. Neuronal loss and degenerated neurons were observed in the hippocampal CA1–CA3 regions of hamsters
inoculated with IC/OSA1-F (B), IC/OSA1-FH (D), IC/F:OSA1ext (E), IC/F:OSA1-F2 (G), or IC/F:I62T&M94V (H). No lesions were seen in the brains of hamsters inoculated with
wild-type IC323 (A) or IC/F:OSA1-F1ext (F). In hamsters inoculated with the IC/OSA1-H (C) virus, mild neuronal damage was restricted to the CA1 ﬁeld of the hippocampus.
Proliferation and activation of astroglia and microglia were also noted in the affected areas. We used the following viruses as inoculates: (A) IC323; (B) IC/OSA1-F; (C) IC/
OSA1-H; (D) IC/OSA1-FH; (E) IC/F:OSA1ext; (F) IC/F:OSA1-F1ext; (G) IC/F:OSA1-F2; and (H) IC/F:I62T&M94V. The CA1, CA2, and CA3 regions, together with the dentate gyrus
(DG), are indicated in panel A. Scale bar for panel A, 500 mm. Panels A, B, C, E, and G show the hippocampal area in the right hemisphere. Panels D, F, and H show the
hippocampal area in the left hemisphere. Arrows indicate the abnormal appearance of the pyramidal cell layer.
M. Ayata et al. / Virology 487 (2016) 141–149 145IC/F:OSA1ext or IC/F:OSA1-F2 (Supplementary Fig. 3E and G), but
no lesions were seen in the brains of hamsters inoculated with
IC/F:OSA1-F1ext (Supplementary Fig. 3F). A relatively old lesion
with neuronal loss and mild astroglial proliferation was found in
the CA1–CA3 ﬁelds of the hippocampi in a hamster inoculated
with IC/F:I62T&M94V that recovered after showing temporary
neurologic signs, and had been killed 10 weeks after viral inocu-
lation (Supplementary Fig. 3H). An immunohistochemical exam-
ination revealed the expression of the N protein in the pyramidalcells in the hippocampi of the hamsters that had been inoculated
with IC/F:OSA1-F2 (Supplementary Fig. 4).Discussion
Genetic diversity among SSPE strains has been demonstrated
(Ayata et al., 1989; Cattaneo et al., 1988a, 1988b; Schmid et al.,
1992), and the sites and extents of mutations differ widely among
M. Ayata et al. / Virology 487 (2016) 141–149146SSPE strains. In a previous study, we showed that mutations in the
F and H genes of the SSPE Osaka-2 strain correlated with MV
neurovirulence in hamsters. In the present study, our ﬁndings
show that mutations in the F and H genes of the Osaka-1 strain are
responsible for its neurovirulence in hamsters. In the Osaka-2
strain, mutations in the F1 region of the extracellular domain of
the F protein appear to be critical (Ayata et al., 2010), and they are
located in the heptad repeat B (HRB) region of the F protein (Eckert
and Kim. 2001; Lamb, 1993). However, in the Osaka-1 strain the
mutations responsible for neurovirulence are located in the HRA
and HRC regions (Plemper and Compans, 2003). Analysis of the
SSPE Osaka-1 and Osaka-2 strains revealed that multiple sub-
stitutions are involved in enhancing cellular fusion, and that these
substitutions are closely related to the neurovirulence of the virus
in hamsters, suggesting that this association is a common feature
among SSPE strains. Although the cytoplasmic domains of the F
protein are frequently altered (Schmid et al., 1992), which is
characteristic of most SSPE strains, including the Osaka-1 and
Osaka-2 strains (Ning et al., 2002), and the cytoplasmic domain
also plays some role in the enhanced fusogenic activity of the virus
(Cathomen et al., 1998a, 1998b), changes in the cytoplasmic
domains of the Osaka-1 and Osaka-2 strains were not involved in
their neurovirulence in our hamster model.
In contrast to our study of the Osaka-2 strain, a single amino
acid substitution in the F protein found in the Osaka-1 strain was
not sufﬁcient to induce high levels of syncytia. However, certain
combinations of substitutions in the extracellular domain of the
Osaka-1 F protein enhanced its fusogenic activity in Vero cells. The
extracellular domain of the F protein appeared to be critical in
conferring neurovirulence. Substitutions in the F2 region of the F
protein were associated with the neurovirulence of the Osaka-1
strain in hamsters. Amino acid substitutions I62T, T82I, and M94V
were found in the F2 region of the Osaka-1 F protein, and a
recombinant MV containing these three mutations induced lethal
encephalitis in hamsters. Among these three substitutions in the
F2 region, the M94V substitution appeared to play an important
role in neurovirulence. The M94V substitution was previously
introduced into the F protein of the recombinant Edmonston tag
strain, which was based on the Edmonston B MV strain (Radecke
et al., 1995). This mutation enhanced cell-to-cell fusion in infected
cells (Heidmeier et al., 2014; Plemper and Compans, 2003).
However, the relationship between mutation and neurovirulence
has not been examined.
We observed no neurovirulence in hamsters inoculated with
recombinant MVs containing three amino acid substitutions in the
F1 extracellular domain. However, viruses containing the A167T
and H419Q substitutions induced small syncytia in Vero cells and
induced mild encephalitis in hamsters. Virus containing
both M94V and A167T substitutions in the F1 and F2 domains,
respectively, induced large syncytia in Vero cells and strong
(lethal) neurovirulence in hamsters. Each amino acid substitution
possibly affected the conformation and function of the F protein to
differing extents.
The locations of residues I62, T82, M94, A167, N191, and H419
were mapped on a homology-based model structure of the MV F
prefusion and postfusion proteins, constructed based on the
crystal structures of the parainﬂuenza virus 5 (PIV5) and human
parainﬂuenza virus 3 (hPIV3) F proteins, respectively (Supple-
mentary Fig. 5). All the residues were located in the globular head
region in the F prefusion form (Supplementary Fig. 5A). Residues
T82 and M94 were located in the HRC domain (Supplementary
Fig. 5, colored orange). The HRC domain is thought to interact with
the HRA domain during cell fusion (Lamb and Jardetzky, 2007),
suggesting that amino acid substitutions in these domains affect
the cell fusogenic activity of the virus. Plemper and Compans
(2003) performed a detailed analysis of the amino acid residues atposition 94, and showed that the residue at this site is crucial for
membrane fusion activity. They suggested that amino acid changes
at this position may modulate the interaction of the F protein with
the H protein or F protein folding, thus reducing the energy barrier
to fusion. Residue A167, which is located at the surface of the
globular head in the F prefusion form (Supplementary Fig. 5A), is
translocated to the inside position of the six-helix bundle in the F
postfusion form (Supplementary Fig. 5B). Because the formation of
the six-helix bundle is critical for membrane fusion, mutation at
this position may modify the fusogenic activity of the protein. The
combination of M94V and A167T is an example of the cooperative
effects of mutations in enhancing the fusogenic activity of the
protein, resulting in viral neurovirulence in the hamster. We did
not identify the step in the conformational change that occurs
during fusion process that is affected by each mutation. However,
our structural models of the F protein suggest that each sub-
stitution identiﬁed in this study contributes independently to
enhancing the membrane fusogenic activity of the protein.
Clustered A-to-G mutations in the MV M gene, known as biased
hypermutation, are the most characteristic feature of the SSPE
strains (Cattaneo et al., 1988a, 1989). The production of infectious
cell-free virus was reduced in cells infected with the recombinant
MV containing the M gene of the Osaka-1 strain. However, ham-
sters inoculated with this virus showed no neurologic signs. This is
consistent with a previous ﬁnding obtained with the Osaka-2
strain (Ayata et al., 2010). Because the M protein interacts with the
N protein and regulates RNA synthesis (Iwasaki et al., 2009), we do
not exclude the possibility that mutations in the M gene con-
tribute to persistent infection in the brain (Patterson et al., 2001).
Cells infected with recombinant MVs containing the F and/or H
proteins of the Osaka-1 strain also produced low levels of infec-
tious cell-free virus. Functional and structural changes in the
envelope-associated proteins (M, F, and H) are common char-
acteristics of SSPE strains, and are likely to contribute to persistent
MV infections in the brain.
Current and previous results suggest that mutations in the F
gene are probably responsible for the neurovirulence of MV in
hamsters. Less signiﬁcantly, mutations in the H gene can also
confer neurovirulence. Hamsters inoculated with MV containing
the H gene of the Osaka-1 strain showed characteristic neurologic
signs, but recovered quickly and survived. A recombinant MV
containing both F and H genes of the Osaka-1 strain was more
neurovirulent. Wild-type MV strains make use of the SLAM
receptor on immunological cells (Erlenhoefer et al., 2001; Hsu
et al., 2001; Tatsuo et al., 2000) or nectin 4 on epithelial cells
(Mühlebach et al., 2011; Noyce et al., 2011). The receptors on Vero
cells and on neural cells in the hamster brain that are used by MV
SSPE strains are yet to be determined (Ishida et al., 2004; Shingai
et al., 2003). Further studies are in progress to determine the
region and amino acid substitutions in the H protein responsible
for the receptor usage and neurovirulence of MV.Conclusion
The characteristics of the strains of MV isolated from SSPE
patients differ from those of strains isolated from patients with
acute measles. The genetic diversity among SSPE strains has been
demonstrated, and the sites and extents of their mutations differ,
as exempliﬁed by the Osaka-1 and Osaka-2 strains. Neurovirulence
is commonly attributed to mutations in the F and H proteins of
these strains. The results of the present study, using the Osaka-1
strain, combined with previous results involving the Osaka-2
strain, indicate that one or two spontaneous mutations in the
extracellular domain of the MV F protein are responsible for lethal
encephalitis in hamsters. Substitutions in the F protein enhance
M. Ayata et al. / Virology 487 (2016) 141–149 147the fusion of infected cells, suggesting that this is a common fea-
ture of MV SSPE strains.Materials and methods
Cells and viruses
B95a cells (Kobune et al., 1990) were cultured in RPMI-1640
medium (Nissui Pharmaceutical Co., Tokyo, Japan) supplemented
with 10% heat-inactivated fetal calf serum (FCS). Vero cells were
cultured in Dulbecco's modiﬁed Eagle's medium (DMEM; Nissui
Pharmaceutical Co.) supplemented with 10% FCS. CHO/SLAM cells
(Tatsuo et al., 2000, a gift from Y. Yanagi) were cultured in DMEM
supplemented with 10% FCS and 500 mg/mL G418 (Nacalai Tesque,
Tokyo, Japan). BSRT7/3 cells (a gift from M. Kawano) were cultured
in DMEM supplemented with 5% FCS and 500 mg/mL G418. All cell
cultures were incubated at 35 °C under 5% CO2.
The MV IC323 strain is a recombinant MV prepared from
plasmid p(þ)MV323. The plasmid was generated using the wild-
type IC-B strain, which was isolated from a patient with acute
measles (Takeda et al., 2000).
Plasmids
We used the mammalian expression vector pME18S containing the
entire F or H protein-coding region, as described previously (Ayata
et al., 2007). The nucleotide sequences of the M, F, and H genes of the
Osaka-1 SSPE strain have been reported previously (Ayata et al., 1998;
Furukawa et al., 2001; Ning et al., 2002). Because the BstEII site occurs
in the coding region but not in the 30 noncoding region of the M gene
of the Osaka-1 strain, synthetic primers were used to destroy the BstEII
site in the coding region (50-3997CCTTCAACCTGCTAGTGACC4016-30 and
50-4016GGTCACTAGCAGGTTGAAGG3997-30), and to create a BstEII site in
the 30 noncoding region (50-4820GCGGTTGGGTCACCTCGATCGC4799-30)
to construct IC/[P-M6U]OSA1-M. To conform to the rule of six
(Calain and Roux, 1993), another primer containing an extra T
was used to create a BstEII site in the 30 noncoding region
(50-4820GCGGTTGGGTCACCTTCGATCGC4798-30) to construct IC/[P-M5U]
OSA1-M. Plasmids encoding mutant F proteins were generated with
polymerase chain reaction (PCR)-based methods. The inserts were
veriﬁed by sequencing with the BigDye Terminator v3.1 Cycle
Sequencing Kit (Life Technologies, Carlsbad, CA, USA) and an auto-
mated sequencer (ABI Prism 310 or 3130xl Genetic Analyzer; Life
Technologies). Plasmids encoding the mutant MV genomes were
based on p(þ)MV323, which encodes the antigenomic full-length
cDNA of the wild-type IC-B strain (Takeda et al., 2000). The generation
of plasmids that produced recombinant viruses containing the M, F, or
H gene has been described previously (Ayata et al., 2010).
Transient expression of F and H glycoproteins and indirect
immunoﬂuorescence
Cells grown in Sonic Seal Slide Wells (Nalge Nunc International,
Rochester, NY, USA) were transfected with F-encoding (0.5 mg/
well) and H-encoding plasmids (0.5 mg/well) using Lipofecta-
mine™ LTX transfection reagent (Life Technologies), according to
the manufacturer's protocol. The transfected cells were incubated
at 35 °C for the appropriate periods. The cells were washed once
with phosphate-buffered saline (PBS; pH 7.4), air dried, and ﬁxed
with a 1:1 acetone:methanol mixture at room temperature for
2 min. A monoclonal antibody directed against the H protein was
used for immunoﬂuorescent staining, as described previously
(Ayata et al., 2007).Preparation of recombinant MVs expressing proteins derived from
SSPE
Recombinant MVs were generated from plasmids containing
the M, F, or H genes of the Osaka-1 SSPE strain using CHO/SLAM
cells and a vaccinia virus carrying the T7 RNA polymerase, vTF7-3,
according to previously described procedures (Ayata et al., 2010;
Takeda et al., 2005). Recombinant viruses with various mutations
in the F gene were prepared with a vaccinia-virus-free method, as
described previously (Seki et al., 2011), with some modiﬁcations.
We used the BSRT7/3 cell line instead of BHK/T7-9 cells, and the
cells transfected with the MV genes were cocultured 1 day after
transfection. To obtain a cell-free viral stock, the infected B95a
cells were treated with cytochalasin D (Sigma, St. Louis, MO, USA),
as previously described (Ishida et al., 2004), and the resulting viral
particles were stored at 85 °C until required.
Virus inoculation into and recovery from hamsters, and histopatho-
logical examination
Female Syrian golden hamsters (3 weeks old; SLC-Japan, Shi-
zuoka, Japan) were anesthetized with sevoﬂurane, and then
inoculated with 50 mL of diluted viral stock in the right cerebral
hemisphere. Selected hamsters from each group were killed in the
terminal stage of infection or at the end of the observation period.
Their brains were removed and subjected to either virus rescue or
histopathological examination. The viruses were recovered from
the brain cells by coculture with B95a cells. Total cellular RNA was
extracted from the recovered virus-infected cells, or directly from
the brain, according to a previously described method (Ayata et al.,
1998). The extracted RNA was reverse transcribed using random
primers, and the regions containing the M, F, or H genes were
ampliﬁed by PCR with speciﬁc primer pairs and sequenced. Whole
brains that were removed were ﬁxed in 10% formalin (Wako Pure
Chemicals, Osaka, Japan). Sections were prepared, stained with
hematoxylin–eosin, and evaluated histopathologically. Selected
sections were immunohistochemically stained with a mouse
monoclonal antibody directed against the MV N protein (clone 58).
All animal experiments were performed according to the Guide for
Animal Experimentation, Osaka City University. The animal
experiments were conducted in a biosafety level 2 (BSL-2)
laboratory at the Laboratory Center of the Medical School, Osaka
City University.
Titration of viruses
The infective titers of the viral stocks were determined by
counting the plaque-forming units (PFUs) in B95a cells or Vero
cells. To measure the production of cell-free virus, B95a cells were
infected with each recombinant MV at a multiplicity of infection of
0.02 PFU/cell. After 72 h, the infectious cell-free virus was pre-
pared by freeze–thawing the infected cells and centrifuging them
(1600 g, 4 °C). The titer, referred to as the 50% tissue culture
infectious dose (TCID50), of each virus was determined on
B95a cells.
Structural modeling of the F protein
Based on the crystal structures of the PIV5 F (Protein Data Bank
[PDB]: 2B9B; Yin et al., 2006) and hPIV3 F proteins (PDB: 1ZTM;
Yin et al., 2005), homology-based structural models of the prefu-
sion and postfusion F proteins of MV strain IC323 were con-
structed with the Molecular Operating Environment software
(Chemical Computing Group Inc., Montreal, Canada). The six
mutated sites found in the OSA1 F protein were evaluated in the
model structure using PyMOL (DeLano, 2002).
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